INS and type 2 diabetes mellitus: In patients with long term type 2 diabetes and suboptimal stable insulin treatment, the addition of pioglitazone but not metformin reduced the level of inflammatory biomarkers such as MMP-9 and hs-CRP and increased insulin sensitivity and adiponectin.